Sigma Planning »

Rigel Pharmaceuticals shares owned by Sigma Planning

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Sigma Planning from 13F filings

Historical chart of Sigma Planning investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Sigma Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Sigma Planning

Quarter filed Position value Share count Share price at filing
2025-12-31 $280k 6.5k 42.83

More positions owned by Sigma Planning

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Div Grwth (DGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Meta Platforms Cl A (META)
Broadcom (AVGO)

View all positions for Sigma Planning

Top funds holding Rigel Pharmaceuticals

BlackRock
State Street Corporation
Vanguard Group
Armistice Capital
Goldman Sachs Group
Marshall Wace
Capitolis Liquid Global Markets
LSV Asset Management
Renaissance Technologies
Acadian Asset Management
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Jane Street
D. E. Shaw & Co
Soleus Capital Management

View all funds holding Rigel Pharmaceuticals